Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.
Cancer prevention research (Philadelphia, Pa.)(2022)
摘要
Our results show that everolimus delays mammary tumor formation in multiple mouse models, suggesting that mTOR inhibitors will be useful for the prevention of ER-negative and triple-negative breast cancer in humans. See related Spotlight, p. 787.
更多查看译文
关键词
mtor pathway,cancer,er-negative
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要